Next Pharmaceuticals Overview

  • Founded
  • 1997
  • Status
  • Acquired/​Merged
  • Employees
  • 11
  • Latest Deal Type
  • Buyout/​LBO
  • Financing Rounds
  • 1

Next Pharmaceuticals General Information


Developer and manufacturer of herbal supplement ingredients. The company develops natural raw materials for the dietary supplement, food and beverage industries and operates various brands which include Relora, Sytrinol, Seditol and Nexrutine.

Contact Information

Ownership Status
Financing Status
Formerly PE-Backed
Primary Industry
Drug Discovery
Primary Office
  • 360 Espinosa Road
  • Salinas, CA 93907
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Next Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Next Pharmaceuticals‘s full profile, request access.

Request a free trial

Next Pharmaceuticals Executive Team (1)

Name Title Board Seat Contact Info
Charles Kosmont Co-Founder, Chief Executive Officer and Chairman
To view Next Pharmaceuticals’s complete executive team members history, request access »

Next Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial